Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells

被引:33
作者
Han, XB
Patters, AB
Chesney, RW
机构
[1] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38103 USA
[2] Lebonheur Childrens Hosp & Med Ctr, Childrens Fdn Res Ctr, Memphis, TN 38103 USA
关键词
D O I
10.1074/jbc.M205939200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Taurine, an intracellular osmolyte whose body pool size is adaptively regulated by the kidney, is required for normal renal development. Overexpression of the p53 tumor suppressor gene in p53 transgenic mice results in renal malformation, suggesting that altered expression of certain p53 target gene(s) involved in renal development may be responsible. This study shows that the taurine transporter gene (TauT is a transcriptional target of p53. Expression of TauT was decreased after activation of p53 by doxorubicin, a DNA-damaging drug, in 293 and NRK-52E renal cells. TauT promoter activity was decreased 5-10-fold by cotransfection of a full-length TauT promoter-reporter construct with p53, which was reversed by cotransfection with a mutant p53 (p53-281). Electrophoretic mobility shift assays using nuclear extracts from p53-expressing (10)1val cells showed a putative p53-binding site in the TauT promoter region, which bound to the p53 in electrophoretic mobility shift assays. Mutation of this p53 consensus sequence abolished binding of p53. These results demonstrate that TauT may represent a downstream target gene of p53 that could link the roles of p53 in renal development and apoptosis.
引用
收藏
页码:39266 / 39273
页数:8
相关论文
共 32 条
[1]   Stress signals utilize multiple pathways to stabilize p53 [J].
Ashcroft, M ;
Taya, Y ;
Vousden, KH .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (09) :3224-3233
[2]  
Bargonetti J, 1997, CELL MOL BIOL, V43, P935
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
Chen XC, 1998, ADV EXP MED BIOL, V442, P397
[5]   RENAL-CORTEX TAURINE CONTENT REGULATES RENAL ADAPTIVE RESPONSE TO ALTERED DIETARY-INTAKE OF SULFUR AMINO-ACIDS [J].
CHESNEY, RW ;
GUSOWSKI, N ;
DABBAGH, S .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2213-2221
[6]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49
[7]  
GEDLEY LA, 1996, GENE DEV, V110, P836
[8]  
Han XB, 2000, ADV EXP MED BIOL, V483, P535
[9]  
Han XB, 2000, ADV EXP MED BIOL, V483, P97
[10]  
Han XB, 1999, J AM SOC NEPHROL, V10, P1874